SCHEMBL22949684

SCHEMBL22949684

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5ccc6c(c5)[Si](c5ccc7ccccc7c5)(c5ccc7ccccc7c5)c5ccccc5-6)cc4)n3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 2/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 3/20 0.36
HPGD P15428 2/20 0.36
ESR1 P03372 3/20 0.35
ESR2 Q92731 3/20 0.35
CYP17A1 P05093 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.33
LMNA P02545 2/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22949327 1.00 MEN1 (0.38) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22949535 0.97 MEN1 (0.38) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22949026 0.96 MEN1 (0.39) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22949664 0.94 MEN1 (0.36) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL23869233 0.92 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL23869124 0.92 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22949610 0.92 MEN1 (0.37) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL23869072 0.90 MEN1 (0.38) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22947283 0.89 MEN1 (0.41) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22572806 0.89 MEN1 (0.39) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 MEN1 2439/4885KMT2A 2115/4885ALDH1A1 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.